Hydroxyurea or chronic exchange transfusions in patients with sickle cell disease: Role of transcranial doppler ultrasound in stroke prophylaxis

Heba Suliman, Yasser Wali, Muna Al Saadoon, Mathew Zechariah, Ranjan R. William, Arunodaya Gujjar, Anil Pathare

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Hydroxyurea is increasingly used in patients with sickle cell disease and acts by several underlying mechanisms. Its usage has been reported to eliminate transfusion needs in children with beta-thalassemia major. It has also been used in sickle cell disease patients on stroke prophylaxis with exchange transfusions who develop transfusional iron overload and is now being considered as a possible alternative to chronic transfusions for secondary stroke prophylaxis. Our case demonstrates a pitfall when using hydroxyurea without monitoring intracranial cerebral vessels for vasculopathic changes; presence of which can predict stroke risk and alert the need for chronic blood transfusions as primary stroke prophylaxis. Transcranial Doppler is a crucial investigation that can reveal elevated cerebral arterial flow velocities.

Original languageEnglish
Pages (from-to)42-44
Number of pages3
JournalJournal of Pediatric Hematology/Oncology
Volume31
Issue number1
DOIs
Publication statusPublished - Jan 2009

Fingerprint

Doppler Ultrasonography
Hydroxyurea
Sickle Cell Anemia
Stroke
beta-Thalassemia
Iron Overload
Blood Transfusion

Keywords

  • Doppler
  • SCD
  • Sickle
  • TCD
  • Transcranial
  • Ultrasound

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Oncology
  • Hematology
  • Medicine(all)

Cite this

@article{9fe3f5f4a5ca426b88892b3074581d4d,
title = "Hydroxyurea or chronic exchange transfusions in patients with sickle cell disease: Role of transcranial doppler ultrasound in stroke prophylaxis",
abstract = "Hydroxyurea is increasingly used in patients with sickle cell disease and acts by several underlying mechanisms. Its usage has been reported to eliminate transfusion needs in children with beta-thalassemia major. It has also been used in sickle cell disease patients on stroke prophylaxis with exchange transfusions who develop transfusional iron overload and is now being considered as a possible alternative to chronic transfusions for secondary stroke prophylaxis. Our case demonstrates a pitfall when using hydroxyurea without monitoring intracranial cerebral vessels for vasculopathic changes; presence of which can predict stroke risk and alert the need for chronic blood transfusions as primary stroke prophylaxis. Transcranial Doppler is a crucial investigation that can reveal elevated cerebral arterial flow velocities.",
keywords = "Doppler, SCD, Sickle, TCD, Transcranial, Ultrasound",
author = "Heba Suliman and Yasser Wali and {Al Saadoon}, Muna and Mathew Zechariah and William, {Ranjan R.} and Arunodaya Gujjar and Anil Pathare",
year = "2009",
month = "1",
doi = "10.1097/MPH.0b013e318190d707",
language = "English",
volume = "31",
pages = "42--44",
journal = "Journal of Pediatric Hematology/Oncology",
issn = "1077-4114",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - Hydroxyurea or chronic exchange transfusions in patients with sickle cell disease

T2 - Role of transcranial doppler ultrasound in stroke prophylaxis

AU - Suliman, Heba

AU - Wali, Yasser

AU - Al Saadoon, Muna

AU - Zechariah, Mathew

AU - William, Ranjan R.

AU - Gujjar, Arunodaya

AU - Pathare, Anil

PY - 2009/1

Y1 - 2009/1

N2 - Hydroxyurea is increasingly used in patients with sickle cell disease and acts by several underlying mechanisms. Its usage has been reported to eliminate transfusion needs in children with beta-thalassemia major. It has also been used in sickle cell disease patients on stroke prophylaxis with exchange transfusions who develop transfusional iron overload and is now being considered as a possible alternative to chronic transfusions for secondary stroke prophylaxis. Our case demonstrates a pitfall when using hydroxyurea without monitoring intracranial cerebral vessels for vasculopathic changes; presence of which can predict stroke risk and alert the need for chronic blood transfusions as primary stroke prophylaxis. Transcranial Doppler is a crucial investigation that can reveal elevated cerebral arterial flow velocities.

AB - Hydroxyurea is increasingly used in patients with sickle cell disease and acts by several underlying mechanisms. Its usage has been reported to eliminate transfusion needs in children with beta-thalassemia major. It has also been used in sickle cell disease patients on stroke prophylaxis with exchange transfusions who develop transfusional iron overload and is now being considered as a possible alternative to chronic transfusions for secondary stroke prophylaxis. Our case demonstrates a pitfall when using hydroxyurea without monitoring intracranial cerebral vessels for vasculopathic changes; presence of which can predict stroke risk and alert the need for chronic blood transfusions as primary stroke prophylaxis. Transcranial Doppler is a crucial investigation that can reveal elevated cerebral arterial flow velocities.

KW - Doppler

KW - SCD

KW - Sickle

KW - TCD

KW - Transcranial

KW - Ultrasound

UR - http://www.scopus.com/inward/record.url?scp=59449095514&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=59449095514&partnerID=8YFLogxK

U2 - 10.1097/MPH.0b013e318190d707

DO - 10.1097/MPH.0b013e318190d707

M3 - Article

C2 - 19125086

AN - SCOPUS:59449095514

VL - 31

SP - 42

EP - 44

JO - Journal of Pediatric Hematology/Oncology

JF - Journal of Pediatric Hematology/Oncology

SN - 1077-4114

IS - 1

ER -